Trial Profile
Phase I Study of RO5490248 Alone and in Combination with Bevacizumab in Patients with Advanced Solid Cancers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Parsatuzumab (Primary) ; Bevacizumab
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Chugai Pharmaceutical
- 07 Jun 2016 New trial record